VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
FONR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
FONRFONAR Corporation
$19.09$118M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

FONR logoFONAR Corporation(FONR)Earnings, Financials & Key Ratios

FONR•NASDAQ
$19.09
15.5× P/E·Price updated Jul 2, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryImaging, radiation, and oncology devices
AboutFONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 39 MRI scanning facilities, including 25 facilities located in New York and 14 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.Show more
  • Revenue$104M+1.4%
  • EBITDA$16M-22.9%
  • Net Income$8M-21.1%
  • EPS (Diluted)1.23-19.6%
  • Gross Margin41.12%-6.3%
  • EBITDA Margin15.62%-24.0%
  • Operating Margin11.12%-30.8%
  • Net Margin7.99%-22.2%
  • ROE5.26%-23.4%

FONR Price & Volume

FONAR Corporation (FONR) stock price & volume — 10-year historical chart

Loading chart...

Stagnant Revenue Growth Masks Defensive Balance Sheet

Investment Thesis • Updated 2026Q3

VerdictNeutral
Growth:Mixed
Profitability:Moderate
Financial:Fortress
Cash Flow:Mixed
Primary Risk:Regional regulatory reimbursement dependency

Key Thesis Takeaways

  • FONAR Corporation maintains a highly conservative financial profile characterized by a 0.24 debt-to-equity ratio and significant liquidity, yet it struggles to translate this stability into meaningful top-line expansion.
  • The company's reliance on a niche diagnostic imaging model in saturated regional markets has led to stagnant revenue growth, with the most recent quarter showing a 2.6% decline.
  • Investors should monitor whether the firm can pivot from its current defensive capital allocation posture toward growth-oriented reinvestment, as current operating margins have compressed from 19.2% in 2024Q2 to 9.2% in 2026Q3.

Verdict Logic

while the company's $53.6 million cash position provides a strong safety net, the lack of growth and the 2.6% revenue decline in 2026Q3 suggest limited upside potential for shareholders.

FONR Growth Metrics

FONAR Corporation (FONR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years4.22%
5 Years4.02%
3 Years2.26%
TTM2.25%

Profit CAGR

10 Years-4.28%
5 Years0.23%
3 Years-12.5%
TTM-20.69%

EPS CAGR

10 Years-4.5%
5 Years-6.81%
3 Years-11.09%
TTM-19.35%

Return on Capital

10 Years14.51%
5 Years9.08%
3 Years7.52%
Last Year5.86%

FONR Recent Earnings

FONAR Corporation (FONR) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
Q2 2026Latest
May 11, 2026
Metric
Actual
Est
EPS
$0.24
—
Rev
$26M
—
Q1 2026
Feb 13, 2026
Metric
Actual
Est
EPS
$0.31
—
Rev
$26M
—
Q4 2025
Nov 10, 2025
Metric
Actual
Est
EPS
$0.34
—
Rev
$26M
—
Q4 2025
Sep 22, 2025
Metric
Actual
Est
EPS
$0.11
—
Rev
$27M
—
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 11, 2026
$0.24
$26M
Q1 2026Feb 13, 2026
$0.31
$26M
Q4 2025Nov 10, 2025
$0.34
$26M
Q4 2025Sep 22, 2025
$0.11
$27M
Based on last 12 quarters of dataView full earnings history →

Peers Comparison

Key metrics vs top competitors for FONAR Corporation (FONR)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
FONR logoFONRFONAR CorporationCurrent
$19.09$117.84M15.521.43%7.99%5.26%—
AEYE logoAEYEAudioEye, Inc.
$7.41$92.58M-29.6414.52%-9.05%-70.95%—
IMXI logoIMXIInternational Money Express, Inc.
$14.59$439.08M13.51-7.72%5.27%16.51%—
GEHC logoGEHCGE HealthCare Technologies Inc.
$64.89$29.52B14.264.84%7.54%14.45%—
PHG logoPHGKoninklijke Philips N.V.
$28.23$26.88B26.56-1.04%5.49%8.96%—
NNOX logoNNOXNano-X Imaging Ltd.
$1.24$86.3M-1.0715.4%-523.83%-51.88%—

Compare FONR vs Peers

FONAR Corporation (FONR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs AEYE

Most directly comparable listed peer for FONR.

Scale Benchmark

vs ISRG

Larger-name benchmark to compare FONR against a more recognizable public peer.

Peer Set

Compare Top 5

vs AEYE, IMXI, GEHC, PHG

FONR SEC Filings & Documents

FONAR Corporation (FONR) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 21, 2026·SEC

Material company update

May 12, 2026·SEC

Material company update

Feb 17, 2026·SEC

10-K Annual Reports

4
FY 2025

Sep 22, 2025·SEC

FY 2024

Sep 27, 2024·SEC

FY 2023

Sep 28, 2023·SEC

10-Q Quarterly Reports

6
FY 2026

May 11, 2026·SEC

FY 2026

Feb 13, 2026·SEC

FY 2025

Nov 10, 2025·SEC

Get notified when FONR posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

FONR Frequently Asked Questions

FONAR Corporation (FONR) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is FONAR Corporation's revenue?

FONAR Corporation (FONR) reported $105.3M in revenue for fiscal year 2025. This represents a 704% increase from $13.1M in 1996.

How fast is FONAR Corporation growing?

FONAR Corporation (FONR) grew revenue by 1.4% over the past year. Growth has been modest.

Is FONR profitable?

Yes, FONAR Corporation (FONR) is profitable, generating $6.7M in net income for fiscal year 2025 (8.0% net margin).

Dividend & Returns
What is FONR's return on equity?

FONAR Corporation (FONR) has a return on equity (ROE) of 5.3%. This is below average, suggesting room for improvement.

What is FONAR Corporation's free cash flow?

FONAR Corporation (FONR) generated $4.5M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in FONR back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →